Brain Pathol
From Bioblast
Revision as of 16:41, 3 January 2018 by Kandolf Georg (talk | contribs) (Created page with "{{Journal |Title=[http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1750-3639 Brain Pathology] }}")
| Journal title and website | Brain Pathology |
|---|
Publications
| Reference | Published | View | |
|---|---|---|---|
| Munoz-Pujol 2022 Brain Pathol | Muñoz-Pujol G, Ortigoza-Escobar JD, Paredes-Fuentes AJ, Jou C, Ugarteburu O, Gort L, Yubero D, García-Cazorla A, O'Callaghan M, Campistol J, Muchart J, Yépez VA, Gusic M, Gagneur J, Prokisch H, Artuch R, Ribes A, Urreizti R, Tort F (2022) Leigh syndrome is the main clinical characteristic of PTCD3 deficiency. https://doi.org/10.1111/bpa.13134 | 2022 | Brain Pathol 33:e13134. PMID: 36450274 Open Access |
| Ruiz 2017 Brain Pathol | Ruiz M, Bégou M, Launay N, Ranea-Robles P, Bianchi P, López-Erauskin J, Morató L, Guilera C, Petit B, Vaurs-Barriere C, Guéret-Gonthier C, Bonnet-Dupeyron MN, Fourcade S, Auwerx J, Boespflug-Tanguy O, Pujol A (2017) Oxidative stress and mitochondrial dynamics malfunction are linked in Pelizaeus-Merzbacher disease. Brain Pathol 28:611-30. | 2017 | PMID: 29027761 |
| Margulies 2015 Brain Pathol | Margulies SS, Kilbaugh T, Sullivan S, Smith C, Propert K, Byro M, Saliga K, Costine BA, Duhaime AC (2015) Establishing a clinically relevant large animal model platform for TBI therapy development: using Cyclosporin A as a case study. Brain Pathol 25:289-303. | 2015 | PMID: 25904045 |
